Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 May 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 203 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 2509 results:
Author Title Type [ Year(Asc)]
2020
R. Flynn, Hedenmalm, K., Murray-Thomas, T., Pacurariu, A., Arlett, P., Shepherd, H., Myles, P., and Kurz, X., “Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee”, Clin Pharmacol Ther, 2020.
G. Simoneau, Moodie, E. E. M., Azoulay, L., and Platt, R. W., “Adaptive Treatment Strategies with Survival Outcomes: An Application to the Treatment of Type 2 Diabetes using a Large Observational Database”, Am J Epidemiol, 2020.
H. Kither, Heazell, A., Bruce, I. N., Tower, C., and Crocker, I., “Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study”, Bjog, 2020.
R. Cushen and Francis, N. A., “Antibiotic use and serious complications following acute otitis media and acute sinusitis: a retrospective cohort study”, Br J Gen Pract, vol. 70, pp. e255-e263, 2020.
S. Ramagopalan, Leahy, T. P., Stamp, E., and Sammon, C., “Approaches for the identification of chronic kidney disease in CPRD-HES-linked studies”, J Comp Eff Res, 2020.
F. Khosrow-Khavar, Filion, K. B., Bouganim, N., Suissa, S., and Azoulay, L., “Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study”, Circulation, vol. 141, pp. 549-559, 2020.
A. Y. S. Wong, Froslev, T., Dearing, L., Forbes, H. J., Mulick, A., Mansfield, K. E., Silverwood, R. J., Kjaersgaard, A., Sorensen, H. T., Smeeth, L., Lewin, A., Schmidt, S. A. J., and Langan, S. M., “The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark”, Br J Dermatol, 2020.
R. Palladino, Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., and Vamos, E. P., “Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes”, BMJ Open Diabetes Res Care, vol. 8, 2020.
B. D. Nicholson, Hamilton, W., Koshiaris, C., Oke, J. L., Hobbs, F. D. R., and Aveyard, P., “The association between unexpected weight loss and cancer diagnosis in primary care: a matched cohort analysis of 65,000 presentations”, Br J Cancer, 2020.
H. Fan, Gilbert, R., O'Callaghan, F., and Li, L., “Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study”, Bmj, vol. 368, p. m331, 2020.
F. Giorgianni, Ernst, P., Dell'Aniello, S., Suissa, S., and Renoux, C., “Beta 2 agonists and the incidence of Parkinson's disease”, Am J Epidemiol, 2020.
J. A. H. Masoli, Delgado, J., Pilling, L., Strain, D., and Melzer, D., “Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality”, Age Ageing, 2020.
M. Gokhale, Hattori, T., Evitt, L., Lenney, W., Nordstrom, B., Collins, J., Schultze, A., and Van Dyke, M. K., “Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England”, Immun Inflamm Dis, 2020.
I. Matthews, Duong, M., Parsons, V. L., Nozad, B., Qizilbash, N., Patel, Y., and Guimicheva, B., “Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK”, PLoS One, vol. 15, p. e0229224, 2020.
E. Ford, Rooney, P., Hurley, P., Oliver, S., Bremner, S., and Cassell, J., “Can the Use of Bayesian Analysis Methods Correct for Incompleteness in Electronic Health Records Diagnosis Data? Development of a Novel Method Using Simulated and Real-Life Clinical Data”, Front Public Health, vol. 8, p. 54, 2020.
F. Khosrow-Khavar, Bouganim, N., Filion, K. B., Suissa, S., and Azoulay, L., “Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer”, Am J Epidemiol, 2020.
S. Chowienczyk, Price, S., and Hamilton, W., “Changes in the presenting symptoms of lung cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary care”, Br J Gen Pract, 2020.
Y. Zhu, Edwards, D., Mant, J., Payne, R. A., and Kiddle, S., “Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study”, BMC Med, vol. 18, p. 78, 2020.
S. Wilkinson, Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas, I. J., and Tomlinson, L. A., “Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care”, Diabetes Obes Metab, 2020.
S. Borghs, Byram, L., Chan, J., Dedeken, P., Logan, J., Kiri, V., Noack-Rink, M., Patsalos, P. N., and Thieffry, S., “Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study”, BMC Neurol, vol. 20, p. 7, 2020.
U. Gungabissoon, Kirichek, O., C. Baou, E., and Galwey, N., “Comparison of long-term use of prolonged-release ropinirole and immediate-release dopamine agonists in an observational study in patients with Parkinson's disease”, Pharmacoepidemiol Drug Saf, 2020.
P. Rockenschaub, Nguyen, V., Aldridge, R. W., Acosta, D., Garcia-Gomez, J. M., and Saez, C., “Data-driven discovery of changes in clinical code usage over time: a case-study on changes in cardiovascular disease recording in two English electronic health records databases (2001-2015)”, BMJ Open, vol. 10, p. e034396, 2020.
J. R. Ayala Solares, Raimondi, F. E. Diletta, Zhu, Y., Rahimian, F., Canoy, D., Tran, J., Gomes, A. C. Pinho, Payberah, A. H., Zottoli, M., Nazarzadeh, M., Conrad, N., Rahimi, K., and Salimi-Khorshidi, G., “Deep learning for electronic health records: A comparative review of multiple deep neural architectures”, J Biomed Inform, vol. 101, p. 103337, 2020.
R. A. Payne, Mendonca, S. C., Elliott, M. N., Saunders, C. L., Edwards, D. A., Marshall, M., and Roland, M., “Development and validation of the Cambridge Multimorbidity Score”, Cmaj, vol. 192, pp. E107-e114, 2020.
C. J. D. Threapleton, Kimpton, J. E., Carey, I. M., DeWilde, S., Cook, D. G., Harris, T., and Baker, E. H., “Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care”, Br J Clin Pharmacol, 2020.
O. Moussa, Ardissino, M., Heaton, T., Tang, A., Khan, O., Ziprin, P., Darzi, A., Collins, P., and Purkayastha, S., “Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study”, Eur Heart J, 2020.
T. P. van Staa, Palin, V., Li, Y., Welfare, W., Felton, T. W., Dark, P., and Ashcroft, D. M., “The effectiveness of frequent antibiotic use in reducing the risk of infection-related hospital admissions: results from two large population-based cohorts”, BMC Med, vol. 18, p. 40, 2020.
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
M. D. Danese, Pemberton-Ross, P., Catterick, D., and Villa, G., “Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom”, Eur J Prev Cardiol, p. 2047487319899212, 2020.
R. Mathur, Palla, L., Farmer, R. E., Chaturvedi, N., and Smeeth, L., “Ethnic differences in the severity and clinical management of type 2 diabetes at time of diagnosis: A cohort study in the UK Clinical Practice Research Datalink”, Diabetes Res Clin Pract, vol. 160, p. 108006, 2020.
M. Besford, Graham, S., Sammon, C., Mehmud, F., Allan, V., Alikhan, R., and Ramagopalan, S., “Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study”, Age Ageing, 2020.
H. Hope, Parisi, R., Ashcroft, D. M., Williams, R., Coton, S., Kosidou, K., Pierce, M., and Abel, K. M., “Fertility trends of women with serious mental illness in the United Kingdom 1992-2017: A primary care cohort study using the clinical practice research datalink”, J Affect Disord, vol. 269, pp. 141-147, 2020.
S. Jarvis, Parslow, R. C., Hewitt, C., Mitchell, S., and Fraser, L. K., “GPs' role in caring for children and young people with life-limiting conditions: a retrospective cohort study”, Br J Gen Pract, 2020.
A. Gayle, Schoof, N., Alves, M., Clarke, D., Raabe, C., Das, P., Del Galdo, F., and Maher, T. M., “Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis”, Adv Ther, 2020.
F. Tyrer, Zaccardi, F., Khunti, K., and Morriss, R., “Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care”, Obesity (Silver Spring), vol. 28, pp. 977-984, 2020.
L. Grønbaek, Otete, H., Ban, L., Crooks, C., Card, T., Jepsen, P., and West, J., “Incidence, prevalence, and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study”, Liver Int, 2020.
M. S. M. Persson, Harman, K. E., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Thomas, K. S., and Gran, S., “Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study”, Br J Dermatol, 2020.
R. Persson, Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A., and Jick, S., “Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study”, Mult Scler Relat Disord, vol. 37, p. 101423, 2020.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., “Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes”, Diabet Med, 2020.
R. Persson, Lee, S., M. Yood, U., Mc, C. M. Wagner, Minton, N., Niemcryk, S., Lindholm, A., Evans, A. M., and Jick, S. S., “Infections in patients diagnosed with multiple sclerosis: A multi-database study”, Mult Scler Relat Disord, vol. 41, p. 101982, 2020.
C. S. Osam, Pierce, M., Hope, H., Ashcroft, D. M., and Abel, K. M., “The influence of maternal mental illness on vaccination uptake in children: a UK population-based cohort study”, Eur J Epidemiol, 2020.
L. E. Clarson, Bajpai, R., Whittle, R., Belcher, J., A. Sultan, A., Kwok, C. S., Welsh, V., Mamas, M., and Mallen, C. D., “Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction”, Heart, 2020.
C. Martinez, Wallenhorst, C., Rietbrock, S., and Freedman, B., “Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
H. J. L. Heerspink, Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding, J. P. H., Rodriguez, L. A. Garcia, Cea-Soriano, L., Kohsaka, S., Nicolucci, A., Lucisano, G., Lin, F. J., Wang, C. Y., Wittbrodt, E., Fenici, P., and Kosiborod, M., “Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study”, Lancet Diabetes Endocrinol, vol. 8, pp. 27-35, 2020.
C. J. Sammon, Leahy, T. P., and Ramagopalan, S., “Nonindependence of patient data in the clinical practice research datalink: a case study in atrial fibrillation patients”, J Comp Eff Res, 2020.
G. Glover, Williams, R., and Oyinlola, J., “An observational cohort study of numbers and causes of preventable general hospital admissions in people with and without intellectual disabilities in England”, J Intellect Disabil Res, 2020.
C. van Durme, Spaetgens, B., Driessen, J., Nielen, J., Sastry, M., Boonen, A., and de Vries, F., “Obstructive sleep apnea and the risk of gout: a population-based case-control study”, Arthritis Res Ther, vol. 22, p. 92, 2020.
D. Alarkawi, Ali, M. S., Bliuc, D., Pallares, N., Tebe, C., Elhussein, L., Caskey, F. J., Arden, N. K., Ben-Shlomo, Y., Abrahamsen, B., Diez-Perez, A., Pascual, J., Perez-Saez, M. J., Center, J. R., Judge, A., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., “Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study”, J Bone Miner Res, 2020.
A. Gadoud, Kane, E., Oliver, S. E., Johnson, M. J., Macleod, U., and Allgar, V., “Palliative care for non-cancer conditions in primary care: a time trend analysis in the UK (2009-2014)”, BMJ Support Palliat Care, 2020.
M. M. Loiacono, Mahmud, S. M., Chit, A., van Aalst, R., Kwong, J. C., Mitsakakis, N., Skinner, L., Thommes, E., Bricout, H., and Grootendorst, P., “Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort study”, Vaccine X, vol. 4, p. 100054, 2020.
[Page last reviewed 5 May 2020]